Compare Fifth Third Bancorp Common Stock (FITB) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fifth Third Bancorp Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Fifth Third Bancorp Common Stock trades at $50.53 (market cap $45.98B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.64 (market cap $2.27B). The key difference: Fifth Third Bancorp Common Stock is far larger — about 20.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Fifth Third Bancorp Common Stock pays a 3.31% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| FITB | SLS | |
|---|---|---|
Market Cap | $45.98B | $2.27B |
Volume | 10,522,320 | 4,179,659 |
Sector | Financials | Health |
52-Week High | $59.37 | $15.46 |
52-Week Low | $40.36 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $63.85B | $2.14B |
Dividend Yield | 3.31% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fifth Third Bancorp Common Stock
Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.
Read more on FITB →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
